FDA Found Anaerobic Bacteria in Sealed Tattoo Inks

The presence of microbes in tattoo inks raises concerns regarding the products’ safety.

Written byShelby Bradford, PhD
| 3 min read
Photograph of the end of a tattoo gun and pots of different colored ink on a napkin.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Tattoos are a longstanding form of self-expression through body art but given their nature of breaking the skin to deposit ink, the safety of the products that parlors use is imperative. While temporary inflammation is normal, in 2012, the Food and Drug Administration (FDA) helped investigate a series of reported severe rashes in people after a tattoo application. The cause turned out to be an ink contaminated with a species of non-tuberculosis mycobacteria (NTM).1 These and other incidences led to product recalls predominantly due to microbial contamination.2

“As a result of that, we started to look into what did we need to do from a regulatory perspective to make sure that these products were safe and being safely used,” said Linda Katz, the director for the Office of Cosmetics and Colors at the FDA, which regulates tattoo and permanent makeup inks.

In their follow up studies, Katz and others from the agency identified contamination with aerobic bacteria in one-third of all the inks assessed between 2015 and 2019.3-5 In a recent study, Katz and her colleagues expanded their investigation to assess contamination with anaerobic microbes. The team identified anaerobic bacteria in addition to aerobic microbes in several tattoo and permanent makeup inks.6 The findings, published in Applied Environmental Microbiology, highlight the need for continued monitoring to ensure the products’ safety.

“When you think about tattoo pigment, which is meant to be [in] a place where it probably doesn't belong forever, if there is contamination, especially with an anaerobe versus an aerobe…anaerobes are much harder for our immune system to combat,” said Adam Friedman, a dermatologist at George Washington University who was not involved with the study. “What's unique about it is that they don't just focus on [NTM] which is usually what the spotlight’s on. They're actually looking at a range of bacteria, both aerobic and anaerobic,” said Friedman.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

For their experiments, the FDA scientists sampled 75 different inks from multiple manufacturers that sold products in the United States by swabbing culture plates for growth in aerobic, anaerobic, and low oxygen conditions. They recovered bacteria from 26 inks. Most products only contained one isolate, although some contained two.

The researchers performed 16S ribosomal RNA to identify the species responsible for the ink contamination. They identified 22 distinct species across all the contaminated products, including two anaerobic species. Eight species are potential pathogens. The most common taxa overall were Staphylococcus species, and all were considered potential pathogens.

“Because of the continued presence that we've been finding of microbial contamination, we're continuing to inspect and to look at these products further,” Katz said. According to the researchers, the recovery of microbes from tattoo and permanent makeup inks, some of which were labeled sterile, prompts further study into the manufacturers’ sterilization methods.

“We need to ensure that those receiving [tattoos] are safe and those who are doing [tattoos] are also safe in the sense of they are not put in potentially liability harm’s way in terms of using contaminated ink,” Friedman said. “This is a very long-standing industry that really deserves the appropriate quality assurance.”

Related Topics

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Assistant Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies